Meet Dr.
Dr. Vidal serves as SVP, Quality Assurance and Process Sciences at Atara Biotherapeutics. He is responsible for leading and advancing the Chemistry, Manufacturing and Control (CMC) components of allogeneic T-cell therapy, including Quality and Quality Control Operations; functionality and compliance; scientific product, process, and analytical development; successful global regulatory approval; and preparation for commercial launch. Dr. Vidal also manages the product and process development pipeline from preclinical stage through commercialization, as well as the industrialization of the cell therapy manufacturing process. Prior to Atara, he served as Vice President of Global Drug Product Process Development, and Vice President of Drug Substance Operations at Amgen. Dr. Vidal has held several senior roles at Wyeth and Pfizer. With over 20 years of experience, he has been involved in the development of more than 100 products, as well as technology transfers, regulatory filing, and product launches in jurisdictions around the globe. He received his bachelor’s degree in molecular biology, master’s degree in molecular endocrinology and biochemistry, and doctorate in cellular molecular biology, all from the University of Puerto Rico, Rio Piedras.
